CANCER IMMUNOTHERAPY

摘要

A method for stimulating an immune response against IL-12R.alpha.2 in a subject having or at risk for developing a disease having cells expressing I L- 13R.alpha.2 includes the steps of formulating the anti-cancer vaccine outsid e of the subject and administering the vaccine to the subject in an amount sufficient to stimulate an immune response against IL-13R.alpha.2 in the subject. A composition for stimulating an immune response agaist IL- 13R.alpha.2 in a subject having or at risk for developing a disease having cells expressing IL-13R.alpha.2 includes an isolated agent that can stimulat e immune response against IL-13.alpha.2.